65 related articles for article (PubMed ID: 11464948)
1. Intrathecal delivery of BDNF.
Schluep M
Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Jun; 1(3):141. PubMed ID: 11464948
[No Abstract] [Full Text] [Related]
2. A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis.
Ochs G; Penn RD; York M; Giess R; Beck M; Tonn J; Haigh J; Malta E; Traub M; Sendtner M; Toyka KV
Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Jun; 1(3):201-6. PubMed ID: 11464953
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal delivery of hepatocyte growth factor from amyotrophic lateral sclerosis onset suppresses disease progression in rat amyotrophic lateral sclerosis model.
Ishigaki A; Aoki M; Nagai M; Warita H; Kato S; Kato M; Nakamura T; Funakoshi H; Itoyama Y
J Neuropathol Exp Neurol; 2007 Nov; 66(11):1037-44. PubMed ID: 17984685
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis and therapy of amyotrophic lateral sclerosis. Introduction.
Serratrice GT; Munsat TL
Adv Neurol; 1995; 68():xix-xx. PubMed ID: 8787218
[No Abstract] [Full Text] [Related]
5. Autonomic dysfunction in ALS: a preliminary study on the effects of intrathecal BDNF.
Beck M; Flachenecker P; Magnus T; Giess R; Reiners K; Toyka KV; Naumann M
Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Jun; 6(2):100-3. PubMed ID: 16036433
[TBL] [Abstract][Full Text] [Related]
6. USAN Council. List No.431. New names. Abrineurin.
Clin Pharmacol Ther; 2000 Oct; 68(4):456. PubMed ID: 11184473
[No Abstract] [Full Text] [Related]
7. Therapeutic benefits of intrathecal protein therapy in a mouse model of amyotrophic lateral sclerosis.
Ohta Y; Kamiya T; Nagai M; Nagata T; Morimoto N; Miyazaki K; Murakami T; Kurata T; Takehisa Y; Ikeda Y; Asoh S; Ohta S; Abe K
J Neurosci Res; 2008 Oct; 86(13):3028-37. PubMed ID: 18543336
[TBL] [Abstract][Full Text] [Related]
8. New hope for treatment of Lou Gehrig's disease.
Piascik P
J Am Pharm Assoc (Wash); 1996 Jun; NS36(6):355-6. PubMed ID: 8697260
[No Abstract] [Full Text] [Related]
9. Epi-arachnoidal drug deposit: a rare complication of intrathecal drug therapy.
Ochs G; Giess R; Bendszus M; Krone A
J Pain Symptom Manage; 1999 Sep; 18(3):229-32. PubMed ID: 10517046
[TBL] [Abstract][Full Text] [Related]
10. [Note on the use of TRH in amyotrophic lateral sclerosis].
Serratrice G
Bull Acad Natl Med; 1985 Oct; 169(7):1013-7. PubMed ID: 3938669
[No Abstract] [Full Text] [Related]
11. Zinc induces motor neuron death via a selective inhibition of brain-derived neurotrophic factor activity.
Post JI; Eibl JK; Ross GM
Amyotroph Lateral Scler; 2008 Jun; 9(3):149-55. PubMed ID: 18574758
[TBL] [Abstract][Full Text] [Related]
12. Effects of brain-derived neurotrophic factor (BDNF) on activity mediated by NMDA receptors in rat spinal cord cultures.
Legrand JC; Darbon P; Streit J
Neurosci Lett; 2005 Dec; 390(3):145-9. PubMed ID: 16125841
[TBL] [Abstract][Full Text] [Related]
13. Exposure to cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients alters Nav1.6 and Kv1.6 channel expression in rat spinal motor neurons.
Gunasekaran R; Narayani RS; Vijayalakshmi K; Alladi PA; Shobha K; Nalini A; Sathyaprabha TN; Raju TR
Brain Res; 2009 Feb; 1255():170-9. PubMed ID: 19109933
[TBL] [Abstract][Full Text] [Related]
14. Stem cells: comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery.
Lunn JS; Hefferan MP; Marsala M; Feldman EL
Growth Factors; 2009 Jun; 27(3):133-40. PubMed ID: 19294549
[TBL] [Abstract][Full Text] [Related]
15. The effects of brain-derived neurotrophic factor (BDNF) administration on kindling induction, Trk expression and seizure-related morphological changes.
Xu B; Michalski B; Racine RJ; Fahnestock M
Neuroscience; 2004; 126(3):521-31. PubMed ID: 15183502
[TBL] [Abstract][Full Text] [Related]
16. Brain-derived neurotrophic factor bound with lecithin derivative showed a markedly enhanced pharmacological potency due to its potent cell membrane affinity followed by prolonged MAPK activation.
Igarashi R; Nakayama T; Takenaga M; Ichinohe M; Yamaguchi Y; Matsumoto K; Kitagawa A; Nakamura N; Kawai S; Nakagawa T; Taiji M; Nakayama C; Mizushima Y
J Control Release; 2005 Feb; 102(2):463-73. PubMed ID: 15653164
[TBL] [Abstract][Full Text] [Related]
17. Autocrine activation of cultured macrophages by brain-derived neurotrophic factor.
Asami T; Ito T; Fukumitsu H; Nomoto H; Furukawa Y; Furukawa S
Biochem Biophys Res Commun; 2006 Jun; 344(3):941-7. PubMed ID: 16631618
[TBL] [Abstract][Full Text] [Related]
18. [Neurotrophic factors and amyotrophic lateral sclerosis (ALS)--therapeutic potential of a new neurotrophic factor: HGF in ALS].
Funakoshi H; Nakamura T
No To Shinkei; 2003 Oct; 55(10):841-5. PubMed ID: 14635512
[No Abstract] [Full Text] [Related]
19. Lecithinized brain-derived neurotrophic factor promotes the differentiation of embryonic stem cells in vitro and in vivo.
Kitagawa A; Nakayama T; Takenaga M; Matsumoto K; Tokura Y; Ohta Y; Ichinohe M; Yamaguchi Y; Suzuki N; Okano H; Igarashi R
Biochem Biophys Res Commun; 2005 Mar; 328(4):1051-7. PubMed ID: 15707984
[TBL] [Abstract][Full Text] [Related]
20. Locomotor exercise alters expression of pro-brain-derived neurotrophic factor, brain-derived neurotrophic factor and its receptor TrkB in the spinal cord of adult rats.
Macias M; Dwornik A; Ziemlinska E; Fehr S; Schachner M; Czarkowska-Bauch J; Skup M
Eur J Neurosci; 2007 Apr; 25(8):2425-44. PubMed ID: 17445239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
